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Efficacy of hepatic computed tomography to detect iron overload in
chronic hemodialysis. The diagnostic efficacy of hepatic computed
tomography density (HCTD) in comparison with serum ferritin for the
detection of iron overload was investigated in uremic patients on
maintenance hemodialysis (HD) and in patients with idiopathic hemo-
chromatosis (IHC). Ten IHC patients, 38 HD patients and 40 healthy
subjects underwent the CT scanning of the liver and determination of
percent saturation of transferrin, serum ferritin concentration and HLA
typing. Liver iron content was determined by histochemical grading and
direct measurement of liver iron concentration either in IHC patients or
in HD patients. Nineteen HD patients were considered to have iron
overload on the basis of liver iron concentration exceeding 3.6 smol/l00
mg dry weight. The mean SD values of HCTD in healthy subjects,
IHC patients, HD patients with iron overload and without iron overload
were 60.2 5.6, 79 5.6, 71.4 3.6, 58 3.8 Hounsfielci Units,
respectively. HCTD showed positive correlations with liver iron con-
centration and serum ferritin either in IHC patients or in HD patients.
The analysis of the diagnostic efficacy of HCTD in comparison with
serum ferritin for the detection of excessive hepatic iron in HD patients
demonstrated that HCTD had higher sensitivity, specificity, positive
and negative predictive values. Cut-off points were arbitrarily fixed to
66 Hounsfield units for HCTD, 400 sg/1iter for serum ferritin and 3.6
tmol/l00 mg dry weight for liver iron concentration, Seventeen HD
patients who possessed the histocompatibility antigens associated with
IHC, namely HLA-A3 and/or HLA-B7 and/or HLA-B14, had liver iron
concentration, serum ferritin and HCTD values higher than those of the
HD patients without these "hemochromatosis alleles". The diagnostic
approach to the disorders of excessive iron storage of the liver may
evolve to a new level of sophistication with the introduction of the CT
scanning. HCTD may be an accurate, non-invasive, alternative to liver
biopsy for the detection of hepatic iron overload in HD patients and in
IHC patients. In HD patients HCTD is more efficient than serum ferritin
in diagnosing iron overload. However, liver biopsy, which permits a
definition of the presence of fibrosis and cirrhosis, maintains its
importance from a standpoint of prognosis and follow-up. In HD
patients the presence of any of the histocompatibility antigens of IHC is
associated with an increased risk of iron overload and excessive hepatic
iron storage.
Idiopathic hemochromatosis and maintenance hemodialysis
are two of the most frequent causes for iron overload. In both
conditions iron overload may be underrecognized for years,
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until tissue damage of the organs involved becomes c1inica1l
manifest. Idiopathic hemochromatosis is a hereditary defect in
the regulation of intestinal iron absorption which leads to a
progressive toxic accumulation of iron in the body resulting in
tissue damage and functional insufficiency of the organs in-
volved [1—33. Idiopathic hemochromatosis is associated with an
abnormal iron-loading gene tightly linked to the A locus of the
HLA complex on chromosome 6 [4—6]. Histologically iron is
found in increased amounts in many organs, particularly in the
liver and pancreas, and to a lesser extent, in the endocrine
glands and the heart [7]. In patients with end-stage kidney
disease on maintenance hemodialysis blood transfusions and
inappropriate iron supplementation are usually responsible for
iron overload [8—11]. Although the ultimate nature of the defect
leading to iron overload in hemodialysis patients remains in part
unknown, recent studies have demonstrated a genetic linkage
between the risk of iron overload and certain histocompatibility
antigens, notably HLA-A3 and/or HLA-B7 and/or HLA-B14
[12—16]. These histocompatibility antigens have been often
found associated with idiopathic hemochromatosis and are
called "hemochromatosis alleles" [4—6]. Iron overload is a
serious problem for some dialysis patients and may be manifest
by hepatosplenic siderosis, cardiomyopathy, proximal myopa-
thy, impairment of phagocytic activity of polymorphonuclear
leukocytes with increased incidence of bacterial infections, and
several endocrine disturbances [8].
Taken together these observations indicate that iron over-
load, when pronounced, should be considered as a harmful
clinical condition. It is known that early diagnosis followed by
periodic phlebotomy can prevent most, if not all, the compli-
cations of idiopathic hemochromatosis [1, 3, 7]. In addition,
several investigators reported the efficacy of the long-term
chelation therapy with desferrioxamine in dialysis patients with
iron overload [17, 18]. Thus, both in hemochromatosis and in
dialysis patients every effort should be made to allow early
diagnosis and to avoid the deleterious consequences of iron
overload.
Useful methods available for the demonstration of iron over-
load include measurement of serum iron, determination of
percent saturation of transferrin, estimation of chelatable iron
stores using desferrioxamine, and measurement of serum fer-
ritin concentration. However, at this time, the definitive test for
the diagnosis of excessive parenchymal iron remains the biopsy
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which permits histochemical examination of tissue iron, mea-
surement of iron concentration and assessment of the extent of
tissue damage. Bone marrow examination and liver biopsy are
considered a reliable guide for iron stores in hemodialysis
patients [19, 201. Recently, it has been demonstrated that iron
deposition in the liver increases hepatic density determined by
computed tomography (CT) [211. In idiopathic hemochromato-
sis hepatic CT density has been proposed as an alternative to
liver biopsy for measuring hepatic iron concentration [22—241.
In the present study we investigated the efficacy of hepatic
CT density in comparison with serum ferritin for the detection
of iron overload in patients on maintenance hemodialysis and in
patients with idiopathic hemochromatosis. The purpose of the
study was to know the answers to the following questions: 1)
Does hepatic CT density have any advantage compared with
serum ferritin? 2) Does hepatic CT density provide an accurate,
noninvasive, alternative to liver biopsy to the direct evaluation
of hepatic iron content? 3) May the diagnostic approach to the
patient with suspected iron overload evolve to a new level of
sophistication with the introduction of the CT scanning?
Methods
Study protocol
Ten patients with idiopathic hemochromatosis, 38 patients
with end-stage kidney disease on maintenance hemodialysis,
and 40 healthy subjects were included in the study after giving
informed consent. All patients and healthy subjects underwent
the CT scanning of the liver and measurement of serum iron,
percent saturation of transferrin and serum ferritin concentra-
tion, All patients with idiopathic hemochromatosis had had a
percutaneous needle biopsy of the liver within four weeks of the
CT scanning and no patient had been venesected between the
time of CT scanning and biopsy. In dialysis patients serum iron,
percent saturation of transferrin and serum ferritin concentra-
tion were measured at three month intervals for a total of at
least four estimations over a period of one year. The mean
values are reported. At the end of the period of the study the
patients underwent the CT scanning of the liver and hepatic iron
determination. HLA typing of dialysis and hemochromatosis
patients were carried out to identify specific alleles known to be
associated with hemochromatosis.
Patients with idiopathic hemochromatosis
Ten patients with idiopathic hemochromatosis were included
in the study. They ranged in age from 40 to 56 years (mean SD
48 5 years). All patients were men. The diagnosis of idio-
pathic hemochromatosis was based on the following criteria
[1—4]: evidence of heavy parenchymal iron overload established
by liver biopsy, evidence of tissue damage consistent with iron
effects, absence of other causes of iron overload, and HLA
typing.
Hemodialysis patients
Thirty-eight patients from the chronic dialysis program were
included in the study. They ranged in age from 27 to 72 years
(mean SD 52.6 10.9 years). Seventeen patients were men
and 21 women. The mean duration of dialysis was 88 months
(range 12 to 120 months). Each patient received regular hemo-
dialysis and was dialyzed four to five hours three times weekly,
against a fluid containing 1 g glucose/liter. Etiology of the
underlying renal disease included chronic pyelonephritis,
chronic glomerulonephritis and polycystic kidney disease. Pa-
tients were excluded from the present study if suffering from
diabetes mellitus, liver disease, malignancies or chronic inflam-
matory disease. None of them had history of alcohol abuse.
None was obese (>20% increase in relative weight). None of
the patients received iron supplementation during the course of
the study, and the extent of such a supplementation prior to the
study was negligible. None received blood transfusions in the
three months preceding the determination of hepatic CT density
and liver iron content.
Healthy subjects
The control group consisted of 40 healthy subjects (19 men
and 21 women). They ranged in age from 31 to 73 years (mean
SD 51.4 17.1 years). None of them had evidence of diabetes
mellitus, liver disease, infection or inflammation disease. None
had history of alcohol abuse. All were well nourished, none was
obese. Hemoglobin, serum iron, percent saturation of transfer-
tin, serum ferritin as well as the biochemical and hematological
markers of alcohol intake and liver disease (mean corpuscular
volume, serum concentrations of y-glutamyl-transpeptidase,
glutamic-pyruvic and glutamic-oxalacetic transaminase) were
within the normal limits.
Iron studies
Serum iron and total iron binding capacity were determined
using standard techniques. Serum ferritin was assayed by a
radioimmunoassay method [25] using a commercial kit (Bio
Rad, Milan, Italy). Normal limits were 18 to 200 p.g/liter for
women and 38 to 350 pg/liter for men. In uremic patients blood
samples were carried out immediately before dialysis. Liver
iron content was determined either by histochemical grading or
by direct measurement of liver iron concentration. Liver sec-
tions were stained using the Prussian blue method [26]. Liver
iron content was graded by the method of Scheuer, Williams
and Muir [271. Liver iron content was graded by an observer
who had no knowledge of the hepatic CT density or clinical
information. Liver iron concentration was measured according
to the Barry's and Sherlock's method [28]. There was a good
correlation between the results of chemical and histochemical
iron grading. Patients were considered to have iron overload if
liver iron concentration exceeded 3.6 jsmolllO0 mg dry liver
weight, as previously indicated by Brissot and coworkers [29].
Most values exceeding this limit corresponded to grades 3 and
4 of histochemical grading.
Hepatic computed tomography density
The CT scan of all patients and healthy subjects were
obtained with a GE CT/T 8000 scanner with 4.5-second scan
time according to the usual protocols using 8 mm thick slices.
No intravenous contrast material was given. Five 1 cm2 areas
were selected at the periphery of the liver slice, approximately
1 cm from the liver edge, avoiding obvious bile ducts, fissures
and infiltrations. The CT densities of these areas were averaged
to obtain the hepatic CT density.
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Table 1. Iron studies, liver biopsy data and hepatic CT attenuation values in patients with idiopathic hemochromatosis
Hepatic CT Liver iron
Transferrin Serum attentuation concentration
Age saturation ferritin value Iron-stain jmolI1OO mg
Patients Sex yr % pg/liter HU Histology grade dry WI
1 M 40 90 2120 90 cirrhosis 4 25
2 M 56 81 1480 79 cirrhosis 4 15
3 M 53 72 1110 75 cirrhosis 4 14
4 M 47 90 1780 81 cirrhosis 4 15
5 M 42 76 1070 74 cirrhosis 4 12
6 M 52 82 1650 79 cirrhosis 4 16
7 M 44 84 1910 87.5 cirrhosis 4 19
8 M 45 80 1380 76 cirrhosis 4 15
9 M 51 74 1040 74 cirrhosis 4 12
10 M 50 70 1170 75 cirhrosis 4 14
Mean SD 48 5 80 7 1471 382 79 5.6 15.7 3.8
Other biochemical and hematological parameters
Hemoglobin and mean corpuscular volume were determined
using standard techniques (Hemalog 8, Technicon Instruments
Co. Basingstoke, UK). The serum concentrations of y-glu-
tamyl-transpeptidase, glutamic-pyruvic and glutamic-oxalacetic
transaminase were measured using a Sequential Multiple Ana-
lyzer with computer system (SMAC, Technicon Instruments
Co. Basingstoke, UK). HLA typing was carried out by a
standard microlymphocytotoxicity technique as previously de-
scribed [30].
Statistical analysis
The significance of difference among mean values was calcu-
lated using the Student's two tailed t-test for unpaired data.
Correlations were assessed by linear regression according to
the method of least squares. We also determined the sensitivity
(how the test is in positive cases), specificity (how the test is in
negative cases), positive predictive value (how accurate the test
is when it gives a positive result) and negative predictive value
(how the test is when it gives a negative result) of hepatic CT
density and serum ferritin concentration in diagnosing iron
overload in dialysis patients, by applying the following equa-
tions:
true positive (tp)
true positive + false negative (fn)
true negative (tn)Specificity =
. .
X 100
true negative + false positive (fp)
Positive predictive value = tp > 100
tp + fp Hemodialysis patients
Negative predictive value
tn X 100
tn + fn
Results
Healthy subjects
The mean SD values of percent saturation of transferrin and
serum ferritin concentration in healthy subjects were 25 12%
and 139 116 tg/liter. The prevalence of the histocompatibility
antigens associated with idiopathic hemochromatosis, namely
HLA-A3, HLA-B7 and HLA-B14 was 25%, 10% and 8%,
respectively. The mean SD value of hepatic CT density was
60.2 5.6 Hounsfield units with a range of 50 to 70 Hounsfield
units. There was no correlation between hepatic CT density and
age. The upper limit of normal for hepatic CT density to
evaluate the diagnostic efficacy of the technique for the deter-
mination of hepatic iron excess was arbitrarily defined as 66
Hounsfield units. This value corresponded approximately to the
mean 1 SD for the whole group of healthy subjects.
Patients with idiopathic hemochromatosis
The values of percent saturation of transferrin, serum ferritin
concentration and hepatic CT density as well as liver biopsy
data (histology, iron-stain grade and measured iron concentra-
tion) are summarized in Table 1. All patients had serum ferritin
concentration above 1000 p.g/liter and percent saturation of
transferrin above 50%. The mean SD values of hemoglobin
and mean corpuscular volume were 14.9 1.4 g/dl and 96 5
fmol/liter, and they did not differ from those of healthy subjects
(14.6 1.3 g/dl and 91 7 fmol/liter). The histocompatibility
antigens HLA-A3 and/or HLA-B7 and/or HLA-B14 were found
in all patients. Their frequencies were 75%, 25% and 25%,
respectively. Liver iron concentration ranged from 12 to 25
prnol/100 mg dry weight. All patients showed a grade 4 of
histochemical liver iron content. The mean SD value of
hepatic CT density was 79 5.6 Hounsfield units with a range
of 72 to 90 Hounsfield units. All the CT values were well above
the defined normal range obtained in healthy subjects. In the
whole group of patients hepatic CT density correlated either
with liver iron concentration (r = 0.93, P < 0.0001) or with
serum ferritin (r = 0.87, P < 0.001).
Sensitivity x 100
The values of percent saturation of transferrin, serum ferritin
concentration, lifetime estimated transfusional iron load and
hepatic CT density as well as liver histology, iron-stain grade
and measured iron concentration in hemodialysis patients are
shown in Table 2. Nineteen patients had iron overload as
indicated by liver iron concentration exceeding 3.6 moYl00
mg dry weight. Comparison of some clinical, biochemical and
hematological parameters for the two groups of patients with
iron overload and without iron overload, respectively, is given
in Table 3. Liver iron concentration ranged from 0.5 to 3.2
mol/100 mg dry weight in patients without iron overload and
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Table 2. Data regarding hepatic CT attenuation value and some clinical, biochemical and histological parameters in hemodialysis patients
from 5.8 to 17 jimol/100 mg dry weight in patients with iron
overload. The mean value of hepatic CT density in dialysis
patients with iron overload was significantly higher than those
of healthy subjects (71.4 3.6 vs. 60.2 5.6 Hounsfield units,
P < 0.0001) and dialysis patients without iron overload (71.4
3.6 vs. 58 3.8 Hounsfield units, P < 0.0001). In turn, the mean
value of hepatic CT density in dialysis patients without iron
overload did not differ from that of healthy subjects (58 3.8
vs. 60.2 5.6 Hounsfield units). In the whole group of patients
on maintenance hemodialysis hepatic CT density closely cone-
lated either with liver iron concentration (r = 0.95, P < 0.0001)
or with serum ferritin (r = 0.9, P < 0.0001). The analysis of the
diagnostic efficacy of hepatic CT density in comparison with
serum ferritin for the detection of excessive hepatic iron is
shown in Table 4. The cut-off point for serum ferritin to
evaluate the diagnostic efficacy of the test in the determination
of iron overload was arbitrarily defined as 400 g/1iter. Hepatic
CT density had higher sensitivity, specificity, positive and
Table 3. Some clinical, biochemical and hematological parameters ir
the 2 groups of hemodialysis patients respectively with iron overloac
and without iron overload
Patients Patients
without iron with iron
overload overload
N=19 N=l9
SexM/F 9/10 8/il
Age years 51 10 53 11
Time on dialysis months 80 43 84 42
Lifetime estimated transfusional 565 780 1368 l63
iron load mg
Hemoglobin gidI 9.1 1.8 9.1 1.7
Mean corpuscular volume 97 7 99 7
fmol/Iiter
Percent saturation of transferrin 22.8 4.5 31 9
Serum ferritin pg/liter 153 115 806 404
Liver iron concentration 1.9 0.9 10.5 3
unol/JOO mg dry weight
Lifetime
estimated Hepatic CT Liver iron
Transferrin Serum transfusional attenuation concentratior
Age saturation ferritin iron load value Liver Iron-stain pinol/100 mg
Patients Sex yr % pg/liter mg HU histology grade dry wt
1 M 41 26 198 2500 62 — 2 2.6
2 M 72 31 436 750 64 fibrosis 2 3.2
3 F 49 17 48 — 54 — 1 0.6
4 F 50 27 197 750 62 — 2 2.7
5 F 46 27 205 2500 59 — 2 2.3
6 M 56 25 148 750 59 — 1 1.8
7 M 56 19 57 — 58 — 1 1.8
8 F 68 19 53 — 55 — 1 1.6
9 M 47 17 40 — 54 — 1 0.7
10 M 30 21 115 750 59 — 2 2.3
11 M 50 22 157 750 60 — 2 2.3
12 F 60 18 51 — 51 — 1 0.5
13 M 49 26 189 — 62 — 2 2.5
14 M 60 29 411 1000 64 fibrosis 2 3.2
15 F 66 18 40 — 53 — 1 1.2
16 F 50 23 173 — 57 — 1 1.2
17 F 40 22 112 — 56 — 1 1.1
18 F 41 18 51 — 54 — 1 0.7
19 F 44 28 229 1000 59 — 2 3.1
20 F 67 44 1600 1000 76 fibrosis 4 15.3
21 M 42 31 900 750 70.5 fibrosis 3 9.5
22 F 58 32 950 — 73 fibrosis 4 10.2
23 M 72 28 840 750 69.5 — 3 8.3
24 F 59 38 980 — 72 fibrosis 4 11.2
25 F 72 25 490 1000 69 — 3 9.5
26 F 54 38 990 — 74 fibrosis 4 11.8
27 F 62 15 315 — 65 — 2 5.8
28 M 42 26 537 2500 76.5 fibrosis 4 13.5
29 F 60 45 1605 6000 75 fibrosis 4 17
30 F 49 24 417 1500 68 — 3 7.1
31 F 27 26 605 — 69 fibrosis 3 8.7
32 M 56 16 331 750 67 — 2 6.8
33 M 54 18 360 750 68 — 3 7.6
34 F 60 24 470 4000 70 fibrosis 4 11.8
35 F 45 43 1250 3000 75 fibrosis 4 13.8
36 M 48 42 1170 3000 76 fibrosis 4 12
37 M 43 35 980 1000 75 fibrosis 4 12.9
38 M 53 29 518 — 68 — 3 6.8
Mean SD 52.6 10.9 26.6 8.2 479±442 967 1330 64.7 7.7 6.2 4.9
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Table 4. Analysis of the diagnostic efficacy of hepatic CT density in
comparison with serum ferritin concentration for the detection of
excessive hepatic iron in hemodialysis patients (N = 38)
Hepatic
Serum ferritin CT density
Sensitivity 84.2 94.7(TP/TP + FN x 100)
Specificity 89.4 100(TN/TN + FP x 100)
Positive predictive value 88.8 100
(TP/TP + FP x 100)
Negative predictive value 85 95(TN/TN + FN x 100)
Cut-off points are: serum ferritin concentration, 400 pg/liter; hepatic
CT density, 66 Hounsfield units; liver iron concentration, 3.6 j.tmol/l00
mg dry weight, Abbreviations are: TP, true positives; TN, true nega-
tives: FP, false positives; FN, false negatives.
negative predictive values. The analysis of HLA typing dem-
onstrated that one or more of the histocompatibility antigens of
hemochromatosis, namely HLA-A3, HLA-B7, HLA-B14, were
present in 17 dialysis patients. The mean values of serum
ferritin, hepatic CT density and liver iron concentration in the
group of patients presenting any of these antigens were signif-
icantly higher than those of the group without these histocom-
patibility antigens. Conversely, the two groups did not differ
with respect to age, duration of hemodialysis, hemoglobin and
mean corpuscular volume. Lifetime estimated transfusional
iron load was slightly, but not significantly, higher in patients
who possessed any of the histocompatibility antigens associ-
ated with idiopathic hemochromatosis (Table 5).
Discussion
Limited information is available on hepatic CT density in
healthy subjects, and reported values vary considerably due to
differences in CT scanners, scanning energies and patient size
[31]. Our data obtained in healthy subjects with normal param-
eters of iron metabolism indicate that the mean value of hepatic
CT density is 60.2 Hounsfield units with an upper limit of 66
Hounsfield units. Liver disease may produce a variety of
changes detectable by CT scanning [32] but, unlike fatty infil-
tration which lowers CT number, the presence of fibrosis,
cirrhosis or increased copper content does not influence this
parameter [33, 34]. Conversely, since iron has a high atomic
number, hepatic density determined by CT is elevated in the
presence of excessive liver iron content.
In the present study we evaluated the diagnostic efficacy of
hepatic CT density in comparison with serum ferritin in the
detection of iron overload in uremic patients on maintenance
hemodialysis and in patients with idiopathic hemochromatosis.
Serum ferritin provides a good indirect index of body iron
stores in hemochromatosis [35], although it may be normal in
the early stage of the disease and there have been some families
reported with normal immunoreactive serum ferritin levels [36,
37]. Howard and coworkers [23] demonstrated that in hemo-
chromatosis patients hepatic CT density provides an index of
exchangeable iron stores but is less sensitive than serum
ferritin. In our study either serum ferritin or hepatic CT density
had an elevated sensitivity in diagnosing iron overload. All
hemochromatosis patients had serum ferritin levels above 1000
Table 5. Comparison of hepatic CT density, liver iron concentration,
and some clinical, biochemical and hematological parameters for
hemodialysis patients with (IHC-HLA) and without (IHC-HLA)
any of the histocompatibility antigens associated with idiopathic
hemochromatosis (HLA-A3, HLA-B7, HLA-B14)
lHCHLA*
patients
IHC-HLA
patients
Significance
P values
Number 17 21
Sex MIF 8/9 9/12
Age years 50 11 52 13 NS
Time on 90 59 84 43 NS
hemodialysis
months
Lifetime estimated 1350 1500 710 1470 NS
transfusional iron
load mg
Hemoglobin g/dl 9.2 1.6 9.5 1.6 NS
Mean corpuscular 98 7 99 6 NS
volume fmol/liter
Percent saturation of 28 9 24 7 NS
transferrin
Serum ferritin 768 393 362 451 0.04
j.tg/liter
Liver iron 8.8 4.8 3.5 3.3 0.01
concentration
p.mol/lOO mg dry
weight
Hepatic CT density 70.5 5.2 61.9 8.9 0.01
Hounsfield units
xg/liter and hepatic CT density values well above the upper
limit of normal, Such an elevated sensitivity of hepatic CT
density is due to the fact that in none of our patients iron
overload coexisted with fatty infiltration of the liver, which may
occur when hemochromatosis is associated with diabetes mel-
litus, alcoholism or obesity.
Serum ferritin is commonly considered a reliable guide for
iron stores in patients with end-stage kidney disease on main-
tenance hemodialysis [18—20, 38—41]. This, however, may be
questioned at least in a number of pathological conditions, not
rarely associated with maintenance hemodialysis, such as acute
or chronic liver disease, especially when associated with hepa-
tocellular necrosis, lymphoma, lymphocytic leukemia and other
malignancies, rheumatoid arthritis and various inflammatory
and infectious states. In these conditions serum ferritin may be
elevated in the absence of iron overload [40]. Furthermore,
normal values for serum ferritin have been proposed in dialysis
patients that, for unexplained reasons, are higher than those of
healthy subjects [42, 43], and that vary considerably from one
author to another. Since the bone marrow and the liver are the
main storage organs in healthy people, each accounting for
about one third of the total body iron stores [44], iron measure-
ments in these organs have been proposed to estimate the iron
overload in patients on maintenance hemodialysis [42, 43, 45, 52].
In the present study liver iron concentration closely corre-
lated either with serum ferritin or with hepatic CT density.
However, the comparison of the efficacy in diagnosing exces-
sive hepatic iron demonstrated that in dialysis patients hepatic
CT density was a more sensitive and specific test than was
serum ferritin. The predictive value of an elevated CT density
was higher than that for serum ferritin. In fact, a high hepatic
CT density provided iron excess in 100% of cases compared
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with approximately 89% for serum ferritin. In addition, the
predictive value of a normal hepatic CT density was higher than
that for serum ferritin. A normal hepatic CT density predicted
normal iron concentration in 95% of cases as compared with
85% for serum ferritin. In practical terms, these data in hemo-
dialysis patients suggest two considerations: 1) patients with
elevated hepatic CT density have a high probability of having
iron overload; and 2) patients with false positive elevations of
serum ferritin could be correctly identified by performing a CT
scan of the liver. Because of its high sensitivity, the simpler,
less expensive, serum ferritin test must be considered as the
first step in the diagnostic approach to the dialysis patient with
presumed iron overload. Because of its high specificity, hepatic
CT density will identify patients with true iron overload from
those with false elevation of serum ferritin concentration.
Furthermore, since abdominal CT scans are being increasingly
used for diagnostic purposes in hemodialysis patients, radiolo-
gists should be on the alert for the possibility of hepatic iron
overload when the hepatic CT density, measured before the
administration of intravenous contrast material, is above 66
Hounsfield units.
What is the role of the CT scanning of the liver in the
approach to the patient with iron overload? Our data have
proven that an accurate diagnosis of iron overload can be made
by noninvasive means, thus confirming previous studies [21—
24]. Certainly, from a diagnostic standpoint in patients with
suspected iron overload CT scanning can be used to assess
hepatic iron levels, providing an efficient alternative to liver
biopsy. However, from a standpoint of prognosis and follow-up
it is useful to define the histologic pattern and the degree of
hepatic injury. More specifically, it is important to know the
presence or absence of fibrosis-cirrhosis on biopsy, since the
presence of such dramatically increases one's risk of hepatic
malignancy, whereas its absence rules that out [31]. Thus,
although the diagnostic approach to the patient with suspected
iron overload has evolved to a new level of sophistication with
the introduction of the CT scanning, liver biopsy, unless
controindicated, should still be considered in these patients.
In the present study the "threshold" of increased hepatic
iron concentration has been set at 3.6 iimol/l00 mg (200 gIl00
mg) dry weight, as previously suggested by Brissot and cowork-
ers [29]. Stated differently, this is 0.2 percent iron by tissue dry
weight. It has been reported that the values of liver iron
concentration in patients with hemochromatosis, including
those with pre-cirrhotic liver injury are consistently in excess of
1000 g/l00 mg (that is, 1.0 percent) dry liver weight [29, 46].
As tissue injury is not expected until liver iron concentrations
are well above 1.0 percent of dry weight, that is, at least fivefold
greater than the threshold level employed in the present study,
we feel that recognizing lesser degrees loading may be impor-
tant so that preventive measures might be taken. In fact, in
these patients with early iron overload state efforts aimed at
removing the excess iron stores (by desferrioxamine therapy)
and at reducing the worsening of the overload (with the use of
erythropoietin in lieu of transfusions) might prevent significant
tissue injury.
Although the nature of the inherited defect in patients with
idiopathic hemochromatosis that leads to inappropriately high
absorption of dietary iron is still unknown, great progress has
been made in the identification of individuals who are at risk for
developing the disease. Recent studies have confirmed a genetic
linkage between idiopathic hemochromatosis and certain histo-
compatibility antigens, notably HLA-A3, HLA-B7, HLA-B14
[4—6]. As with most HLA associations, however, the increased
frequencies of the HLA aplotypes in idiopathic hemochroma-
tosis are neither absolute nor diagnostic [311. In our experience
the frequency of HLA-A3 in patients with idiopathic hemochro-
matosis and in healthy controls was 75% and 25%, respectively.
These data are coincident with those of Edwards, Skolnick and
Kushner [61, who reported that 75% of patients with idiopathic
hemochromatosis had the HLA-A3 antigen compared with
approximately 30% in the normal population. Thus, although
HLA typing provides information on gene frequencies and may
be useful in evaluating families with the disease, it is of little
clinical value as a marker of idiopathic hemochromatosis in
individual subjects, unless it is established from family studies
that the hemochromatosis gene is likely to be present.
Blood transfusions and parenteral iron are frequently given to
patients on hemodialysis with the aim of correcting chronic
anemia. However, it has been shown that an indiscriminated
iron supplementation may lead to iron overload [8—11]. Breg-
man and coworkers [14] demonstrated that the dialysis patients
who possessed any of the histocompatibility antigens associ-
ated with idiopathic hemochromatosis, such as, HLA-A3 and/or
HLA-B7 and/or HLA-B14, were at increased risk of iron over-
load. Recent studies [12, 13] have demonstrated that repeated
blood transfusions and iron parenteral administration can in-
duce higher serum ferritin level in hemodialysis patients with
"hemochromatosis alleles" than in patients without these his-
tocompatibility antigens, thus suggesting that iron overload in
hemodialysis is a histocompatibility-linked disorder. However,
in subjects at risk for idiopathic hemochromatosis the histocom-
patibility antigens appear only to act as a linked marker for the
gene of idiopathic hemochromatosis, and the HLA loci are not
thought to influence iron metabolism [47]. The gene for idio-
pathic hemochromatosis is uncommon in the general population
[48], and in normal subjects the possession of HLA-A3, HLA-
B7 and HLA-B14 is not associated with increased levels of
serum iron or other indices of increased iron stores [49].
Furthermore, recently Maher and Curtis [50] have reported that
dialysis patients with HLA-A3 and/or HLA-B7 and/or HLA-B14
do not appear to be at increased risk of iron overload.
In view of these apparent contradictions, and since hepatic
CT density provides a direct index of tissue iron storage we
decided to evaluate whether hepatic iron overload and in-
creased CT values are associated with the presence of the
"hemochromatosis alleles" in patients on maintenance hemo-
dialysis. Hemosiderosis of the liver complicating parenteral
iron therapy in patients on hemodialysis was first described by
Curtis, Eastwood and Smith [511, but further reports of paren-
chymal damage are scanty [52]. In the present study the dialysis
patients who possessed the HLA-A3 and/or HLA-B7 and/or
HLA-B14 had liver iron concentrations significantly higher than
the patients without these HLA antigens. Furthermore, the
mean values of hepatic CT density and serum ferritin in the
patients with "hemochromatosis alleles" were significantly
higher when compared either with patients without these HLA
antigens or with healthy subjects. Since the lifetime estimated
transfusional iron load in these patients was slightly, but not
significantly, higher than patients without "hemochromatosis
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alleles" our data suggest that in patients on maintenance
hemodialysis the presence of any of the histocompatibility
antigens of idiopathic hemochromatosis is associated with an
increased risk of iron overload and hepatic iron storage. How-
ever, as in the group of dialysis patients with iron overload the
frequency of HLA-A3, HLA-B7 and HLA-B14 was 31.5%,
36.8% and 26.3%, respectively, the information given by HLA
typing is of less value as a marker of iron overload in the
individual patient.
In summary, although our data are strictly preliminary, the
present study suggests a few considerations: 1) the diagnostic
approach to the disorders of excessive iron storage of the liver
may evolve to a new level of sophistication with the introduc-
tion of the CT scanning; 2) hepatic CT density may be an
accurate, noninvasive, alternative to liver biopsy for the detec-
tion of hepatic iron overload in hemodialysis patients as well as
in patients with idiopathic hemochromatosis; 3) however, liver
biopsy, which permits a definition of the presence of fibrosis
and cirrhosis, maintains its importance from a standpoint of
prognosis and follow-up of these patients; 4) liver iron excess is
highly probable if hepatic CT density exceeds 66 Hounsfield
units; 5) in dialysis patients hepatic CT density is more efficient
than serum femlin in diagnosing iron overload; 6) the finding of
an elevated serum ferritin concentration should indicate the CT
scan of the liver for confirmation of presumable iron overload;
7) in dialysis patients the presence of any of the histocompati-
bility antigens of idiopathic hemochromatosis is associated with
an increased risk of iron overload and excessive hepatic iron
storage; and 8) hepatic CT density, which provides a direct
evaluation of tissue iron storage, and serum ferritin, an indirect
index of body iron stores, complete each other in the diagnostic
approach to the patient with suspected iron overload.
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